150 related articles for article (PubMed ID: 8416794)
21. Tumor promoter enhances mitogenesis by PDGF with little effect on PDGF binding.
Eide BL; Krebs EG; Ross R; Pike LJ; Bowen-Pope DF
J Cell Physiol; 1986 Feb; 126(2):254-8. PubMed ID: 3003126
[TBL] [Abstract][Full Text] [Related]
22. Gangliosides inhibit platelet-derived growth-factor-stimulated increases in intracellular calcium in Swiss 3T3 cells.
Guan Z; Stokes BT; Van Brocklyn J; Yates AJ
Biochim Biophys Acta; 1992 Sep; 1136(3):315-8. PubMed ID: 1520706
[TBL] [Abstract][Full Text] [Related]
23. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of basic fibroblast growth factor-mediated tyrosine phosphorylation and protein synthesis by PD 145709, a member of the 2-thioindole class of tyrosine kinase inhibitors.
Fry DW; Nelson JM
Anticancer Drug Des; 1995 Dec; 10(8):607-22. PubMed ID: 8595121
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation.
Zhou H; Wang DA; Baldini L; Ennis E; Jain R; Carie A; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Jun; 4(12):2376-86. PubMed ID: 16763682
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of bradykinin receptors and bradykinin-induced Ca2+ mobilization, tyrosine phosphorylation, and DNA synthesis by autocrine factors, tumor necrosis factor alpha, and interferon beta in Swiss 3T3 cells.
Kiehne K; Rozengurt E
J Cell Physiol; 1995 Mar; 162(3):367-77. PubMed ID: 7532178
[TBL] [Abstract][Full Text] [Related]
27. Distribution of intracellular free calcium in quiescent BALB/c 3T3 cells stimulated by platelet-derived growth factor.
Tucker RW; Fay FS
Eur J Cell Biol; 1990 Feb; 51(1):120-7. PubMed ID: 2328733
[TBL] [Abstract][Full Text] [Related]
28. Suramin binds to platelet-derived growth factor and inhibits its biological activity.
Hosang M
J Cell Biochem; 1985; 29(3):265-73. PubMed ID: 4077932
[TBL] [Abstract][Full Text] [Related]
29. Effects of platelet-derived growth factor and fibroblast growth factor on free intracellular calcium and mitogenesis.
Tucker RW; Chang DT; Meade-Cobun K
J Cell Biochem; 1989 Feb; 39(2):139-51. PubMed ID: 2715198
[TBL] [Abstract][Full Text] [Related]
30. Domain-dependent modulation of PDGFRbeta by ganglioside GM1.
Oblinger JL; Boardman CL; Yates AJ; Burry RW
J Mol Neurosci; 2003 Apr; 20(2):103-14. PubMed ID: 12794304
[TBL] [Abstract][Full Text] [Related]
31. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.
Bremer EG; Schlessinger J; Hakomori S
J Biol Chem; 1986 Feb; 261(5):2434-40. PubMed ID: 2418024
[TBL] [Abstract][Full Text] [Related]
32. Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation.
Chu JW; Sharom FJ
Immunology; 1995 Mar; 84(3):396-403. PubMed ID: 7751022
[TBL] [Abstract][Full Text] [Related]
33. Preferential inhibition of platelet-derived growth factor-stimulated DNA synthesis and protein tyrosine phosphorylation by nordihydroguaiaretic acid.
Domin J; Higgins T; Rozengurt E
J Biol Chem; 1994 Mar; 269(11):8260-7. PubMed ID: 7510683
[TBL] [Abstract][Full Text] [Related]
34. Activation of platelet-derived growth factor (PDGF) receptor dephosphorylation in intact Swiss 3T3 cells by elevators of intracellular Ca2+ and cAMP.
Böhmer FD; Böhmer SA
FEBS Lett; 1996 Aug; 391(1-2):219-22. PubMed ID: 8706921
[TBL] [Abstract][Full Text] [Related]
35. Gangliosides inhibit PDGF-induced signal transduction events in U-1242 MG human glioma cells.
Saqr HE; Walters JD; Guan Z; Stokes BT; Yates AJ
Neurochem Res; 1995 Nov; 20(11):1389-95. PubMed ID: 8786826
[TBL] [Abstract][Full Text] [Related]
36. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.
Rusnati M; Tanghetti E; Urbinati C; Tulipano G; Marchesini S; Ziche M; Presta M
Mol Biol Cell; 1999 Feb; 10(2):313-27. PubMed ID: 9950679
[TBL] [Abstract][Full Text] [Related]
37. Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting.
Cirri P; Chiarugi P; Taddei L; Raugei G; Camici G; Manao G; Ramponi G
J Biol Chem; 1998 Dec; 273(49):32522-7. PubMed ID: 9829986
[TBL] [Abstract][Full Text] [Related]
38. Modulation of human myelopoiesis by human gangliosides.
Kaucic K; Grovas A; Li R; Quinones R; Ladisch S
Exp Hematol; 1994 Jan; 22(1):52-9. PubMed ID: 8282059
[TBL] [Abstract][Full Text] [Related]
39. Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells.
Slevin M; Kumar S; He X; Gaffney J
Int J Cancer; 1999 Jul; 82(3):412-23. PubMed ID: 10399959
[TBL] [Abstract][Full Text] [Related]
40. Gangliosides stimulate astroglial cell proliferation in the absence of serum.
Katoh-Semba R; Facci L; Skaper SD; Varon S
J Cell Physiol; 1986 Jan; 126(1):147-53. PubMed ID: 3944195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
